healthprotocol.wiki

Protocols Evidence Outcomes

medication-myocardial-infarction-abciximab-heparin-aspirin-thrombolysis-rescue-combined

Outcomes

01
safety-major-bleeding-events-count-cohort-measured
1 evidence row
- di-pasquale_2003_rct_safety-and-tolerability-of-abciximab-in-patients-with-acute-myocardial-infarction-and-failed-thrombolysis
02
vitals-cardiac-angina-events-30-day-count-change-measured
1 evidence row
- di-pasquale_2003_rct_safety-and-tolerability-of-abciximab-in-patients-with-acute-myocardial-infarction-and-failed-thrombolysis
03
vitals-cardiac-infarct-artery-patency-timi-flow-grade-3-binary-measured
1 evidence row
- di-pasquale_2003_rct_safety-and-tolerability-of-abciximab-in-patients-with-acute-myocardial-infarction-and-failed-thrombolysis
04
vitals-cardiac-reperfusion-door-to-balloon-time-below-90-minutes-binary-measured
1 evidence row
- di-pasquale_2003_rct_safety-and-tolerability-of-abciximab-in-patients-with-acute-myocardial-infarction-and-failed-thrombolysis

Evidence

1rows

On this page

Permalink

/protocols/medication-myocardial-infarction-abciximab-heparin-aspirin-thrombolysis-rescue-combined

healthprotocol.wiki

A community-driven, evidence-based health registry. Built for transparency.